Innovative Solution to Predict Drug Shortages in Advance
TraceLink Inc. has been awarded a Bronze award by the prestigious Merit Awards for Healthcare Innovation for its groundbreaking Product Availability Intelligence (PAI) solution. PAI harnesses the collective intelligence of the TraceLink network to identify potential drug shortages up to 90 days in advance, enabling proactive measures to mitigate these shortages. This innovative solution is a game-changer in addressing the critical issue of escalating drug shortages in the United States.
Impact on Patient Care and Healthcare Industry
Customer testimonials and case studies demonstrate the positive impact of TraceLink's PAI solution on patient care and the healthcare industry as a whole. Boston Medical Center, one of TraceLink's partners, has seen significant improvements in patient care by implementing forward-thinking strategies to anticipate and manage drug shortages. In 2023, TraceLink's PAI successfully predicted 70% of active drug shortages, helping healthcare providers avert critical medication shortages and ensure the availability of essential medicines for hundreds of thousands of patients.
Recognition and Commitment to Innovation
The Merit Awards for Healthcare recognize organizations that leverage technology to address pressing healthcare challenges. TraceLink's recognition for its PAI solution highlights the company's commitment to driving innovation in the healthcare sector. By successfully predicting and mitigating drug shortages, TraceLink is at the forefront of digital transformation in healthcare, ensuring that patients receive the medications they need when they need them. The award reinforces TraceLink's dedication to advancing technology to meet the evolving complexities of the global healthcare supply chain.